Find a Research Expert

Experts
 Menu

Graham Pidgeon

Institution

Trinity College Dublin

Contact

Subjects

Biochemistry

Medicine & Nursing

Details
Publications 38
As first author 11
As last author 14
Unique topics 339
Collaborations 48
Sources 9
Are you Graham Pidgeon? Click here to provide feedback on your profile.
All
2019
2018
2016
2015
2014
2013
2012
2011
2010
Earlier
All
2019
2018
2016
2015
2014
2013
2012
2011
2010
Earlier

2019

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
2018

Innovative technologies changing cancer treatment
2018

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
2016

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo.
2016

Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.
2016

Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma.
2016

The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials.
2015

The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials.
2015

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
2014

Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma.
2014

Leptin and adiponectin receptor expression in oesophageal cancer.
2014

Prognostic significance of neuroepithelial transforming gene 1 in adenocarcinoma of the oesophagogastric junction.
2014

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
2013

Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.
2012

Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.
2011

COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention
2011

Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
2011

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
2011

MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
2011

MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma.
2011

Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue
2011

Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
2011

T lymphocyte activation in visceral adipose tissue of patients with oesophageal adenocarcinoma.
2011

The SGBS cell strain as a model for the in vitro study of obesity and cancer.
2010

Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.
2010

Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma.
2010

Leptin and gastro-intestinal malignancies.
2010

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery.
2010

Obesity and gastrointestinal cancer.
2010

The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer
2009

Building a bioresource for esophageal research: lessons from the early experience of an academic medical center.
2007

Lipoxygenase metabolism: roles in tumor progression and survival.
2006

COX-2 protects against thrombosis of the retinal vasculature in a mouse model of proliferative retinopathy.
2003

Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
2002

Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
2001

Effect of surgery and endotoxin on metastatic tumor growth and regulation of VEGF expression and angiogenesis by endotoxin
2001

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
1999

The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease

These arethe9 unique sources for Graham Pidgeon's 38 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 1
Ireland -> Dublin Institute of Technology 2
Ireland -> Dublin Institute of Technology -> PubMed 2
Ireland -> Royal College of Surgeons in Ireland 3
Ireland -> TU Dublin 1
Ireland -> Trinity College Dublin 34
Ireland -> Trinity College Dublin -> PubMed 17
Ireland -> University College Dublin 1
Ireland -> University of Limerick 1

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.